BSX Q1 2018 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$103B

Q1 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2.4B+10.1% YoY

Gross Profit

$1.6B66.8% margin

Operating Income

$457M19.2% margin

Net Income

$298M12.5% margin

EPS (Diluted)

$0.21

QoQ Revenue Growth

-1.2%

Cash Flow

Operating Cash Flow

$193M

Free Cash Flow

$30M

Stock-Based Comp.

$36M

Balance Sheet

Total Assets

$19.2B

Total Liabilities

$12.2B

Stockholders' Equity

$7.0B

Cash & Equivalents

$287M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.4B	$2.2B	+10.1%
Gross Profit	$1.6B	$1.4B	+17.0%
Operating Income	$457M	$308M	+48.4%
Net Income	$298M	$290M	+2.8%

Revenue Segments

Cardiovascular

$933M57%

MedSurg

$711M43%

Geographic Segments

UNITED STATES

$1.3B55%

Non-US

$1.1B45%